Drugs with this side effect
- 1,25(OH)2D3
- 5-ASA: postmarketing, 0% - 2%
- 5-FU: 1%
- BCNU: 1- 10% - 13.6%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: common
- Cancidas
- Colimycin M
- D-cycloserine
- FK463
- Fe(III
- Gd-DTPA
- Ge-132: 2%
- Goserelin
- Implanon: postmarketing
- K779: 1% - 33%
- Kaluril
- L-Dmp: 2.3%
- Leuprorelin
- LiOH
- Lisinopril: 0.6% - 0.8%
- Lyxumia
- MK-462
- Madopar
- Meropenem anhydrous
- Metrodin
- N-carbamylglutamate
- NTBC
- Octreotide
- Oestrogen
- Sativex
- Stalevo 50: 0% - 2%
- Supremon
- Triptorelin
- UDCA
- VACV: 0.9% - 23%
- Zyprexa Relprevv: very common
- acamprosate
- acebutolol
- acetaminophen
- acitretin: postmarketing
- acyclovir: very rare, common
- agomelatine
- alfentanil
- allopurinol
- almotriptan: frequent, 1% - 5%
- alprazolam: 3.2% - 23%
- amantadine
- amifostine
- amiloride
- amisulpride: 3% - 4%
- amlodipine: 0.3% - 1.6%
- amlodipine besylate: 0.3% - 1.6%
- amobarbital
- amphetamine
- amphotericin B
- anagrelide: 1-5%
- anastrozole
- anthracycline
- apomorphine: 35%
- apraclonidine: postmarketing
- aprepitant
- aripiprazole: 4% - 23%
- arsenic
- arsenic trioxide
- articaine
- asenapine: 9.92% - 24%
- atazanavir: uncommon
- atomoxetine: very common, 4% - 11%
- atorvastatin
- atropine
- avanafil
- azelastine: 1.44% - 11.5%
- azithromycin: postmarketing
- baclofen: very common, 5.7% - 20.9%
- bazedoxifene: common
- benazepril: 1.6%
- benazeprilat: 1.6%
- bendamustine
- benzathine penicillin
- betahistine: very rare
- bexarotene
- bicalutamide: 3% - 1-5%
- bimatoprost
- bisoprolol
- bosentan
- brimonidine: postmarketing, uncommon, 55%
- brinzolamide: postmarketing
- bromocriptine: postmarketing, common
- budesonide
- bupivacaine: 0% - 5.15%
- buprenorphine: 2% - 14%
- bupropion: 2% - 3%
- busulfan
- butabarbital
- butorphanol: 7.7% - 43%
- cabergoline: postmarketing, 2.16% - 18.3%
- candesartan
- candesartan cilexetil
- captopril: postmarketing
- carbamazepine: very common, 12% - 32%
- carbidopa
- carvedilol: 1.2%
- cefaclor: rare
- cefazolin
- cefdinir
- cefditoren
- cefpodoxime
- cefprozil
- ceftobiprole
- cefuroxime
- cefuroxime axetil
- celecoxib
- celiprolol
- cephem
- cerivastatin
- cetirizine: 1.9% - 23.9%
- cevimeline
- cidofovir
- cilazapril
- cimetidine
- ciprofloxacin
- citalopram: 2% - 18%
- cladribine: uncommon
- clarithromycin
- clobazam: 16% - 32%
- clofarabine: common
- clomipramine: 46% - 54%
- clonazepam: 7% - 50%
- clonidine: 2% - 38%
- clozapine: 25% - 46%
- cobicistat: common
- codeine
- copolymer 1
- cyclizine
- cyclobenzaprine: 1% - 100%
- cyclopentolate
- cysteamine: uncommon
- cytarabine: 2% - 12%
- dantrolene: 12.9% - 16.7%
- darifenacin: postmarketing
- darunavir
- dasatinib
- deferiprone: postmarketing
- delamanid
- delavirdine
- delta 9-THC
- deprenyl: postmarketing, 3%
- desloratadine: 1.93% - 2.1%
- desmopressin: 0.4%
- desvenlafaxine: 4% - 12%
- dexmedetomidine
- dexrazoxane
- dextromethorphan: very rare
- diazepam: 23%
- diclofenac: rare, 1%
- dicyclomine: postmarketing, 9%
- diflunisal
- dihydrocodeine: common
- dihydroergotamine: 3%
- diltiazem: 1.27%
- dipyridamole: 0.03%
- docetaxel
- donepezil: 1% - 2%
- dorzolamide
- doxazosin: 1.2% - 5%
- doxepin: 6% - 9%
- doxercalciferol
- doxorubicin: common, 5.1%
- doxycycline
- duloxetine: 5% - 21%
- efavirenz: common, 0% - 4%
- eletriptan: 3% - 7%
- elvitegravir: uncommon
- entacapone: 2%
- entecavir: uncommon, common, 0% - 1%
- eprosartan
- ertapenem
- eslicarbazepine
- eslicarbazepine acetate
- esmolol: 3%
- esomeprazole magnesium: 1.9%
- estazolam: 42%
- estradiol
- ethosuximide
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib: postmarketing
- etravirine
- everolimus
- exenatide: postmarketing, rare
- famciclovir: very rare, postmarketing, uncommon, 0.6% - 1.2%
- famotidine
- febuxostat
- felbamate: 19.3% - 48.4%
- felodipine
- fenofibrate
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 20%
- ferumoxytol: postmarketing
- fesoterodine: postmarketing
- fexofenadine: 0.7% - 2.8%
- finasteride: 1.7% - 3.7%
- flecainide
- fluconazole: postmarketing
- flumazenil
- fluoxetine: very common, 5% - 17.1%
- flurbiprofen
- fluvoxamine: common, frequent, 4% - 27%
- fondaparinux: rare
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: uncommon
- fosphenytoin: 6.7% - 27.3%
- frovatriptan
- gabapentin: 1.2% - 27%
- gadobenate dimeglumine
- gadodiamide
- gadolinium
- gadopentetate
- gadoversetamide
- galantamine: 1.7% - 4%
- ganciclovir
- gatifloxacin
- gemcitabine: common, 0% - 30%
- gemfibrozil
- gemifloxacin
- glimepiride
- glipizide
- glucose
- granisetron: common, 1% - 15%
- guanfacine: postmarketing, 18% - 38%
- haloperidol
- homatropine
- hydrochlorothiazide
- hydrocodone: 0.662% - 4.71%
- hydromorphone: postmarketing, 0.746% - 14.8%
- hydroxybutyrate: 1% - 8%
- ibuprofen: 22%
- ifosfamide
- iloperidone: 9% - 15%
- imatinib: infrequent, uncommon
- imipramine: common
- imiquimod: uncommon, 0.1%
- indapamide
- indinavir: 1% - 3.6%
- indomethacin: 1% - 2%
- insulin detemir
- iodixanol
- iohexol
- iopromide
- iotrolan
- ioversol
- ioxilan
- ipratropium bromide
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- irinotecan: 1.3% - 9.4%
- isomannide
- isosorbide-5-mononitrate
- isradipine
- itraconazole: 1%
- ivermectin: 0.9%
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine
- labetalol
- lacosamide: 0% - 36%
- lamivudine
- lamotrigine: 2% - 17%
- lansoprazole
- lenalidomide
- lercanidipine: rare
- letrozole: uncommon, 2% - 9%
- leuprorelin acetate: 8.51%
- levetiracetam: 1.67% - 23%
- levocabastine
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- linezolid
- lisdexamfetamine dimesylate: postmarketing, 2%
- lisuride
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin
- lomitapide
- loratadine
- lorazepam: 1.54% - 3.75%
- lormetazepam
- losartan
- loxapine: very common
- lurasidone: 8% - 26%
- malvidin: postmarketing
- maprotiline
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing
- mefenamic acid
- mefloquine: postmarketing
- melatonin
- meloxicam: 0% - 1.1%
- memantine: 3% - 3.42%
- meropenem
- mesna: 6.7% - 12%
- metformin
- methotrexate
- methylphenidate: 1%
- metipranolol
- metoclopramide
- metoprolol: postmarketing, rare, uncommon
- midazolam: common
- midodrine
- mifepristone: 10%
- milnacipran
- minocycline: 1.93%
- mirtazapine: postmarketing, 10% - 54%
- mitotane: 25%
- mitoxantrone
- moclobemide
- modafinil
- montelukast
- morphine: postmarketing, 3%
- moxifloxacin
- moxonidine: postmarketing
- mycophenolate mofetil: 10.4% - 11.1%
- mycophenolic acid
- nabilone: postmarketing
- nabumetone: 2%
- nalbuphine
- nalmefene
- naltrexone: postmarketing, 2%
- naproxen
- naratriptan: rare
- nebivolol: postmarketing
- nefazodone
- nelarabine: 0% - 23%
- nelfinavir
- nevirapine: postmarketing
- niacin
- nicardipine
- nicorandil: uncommon
- nicotine
- nifedipine: postmarketing, 1.5%
- nisoldipine
- nitazoxanide
- nitroglycerin
- nizatidine: 1.9%
- norfloxacin: postmarketing
- ofloxacin
- olanzapine: very common, 3% - 39.1%
- olopatadine: postmarketing, 0.337% - 0.852%
- omeprazole: postmarketing, uncommon, common, 1.9%
- oxaliplatin
- oxaprozin
- oxcarbazepine: very common, 2.4% - 36%
- oxybutynin: postmarketing, common, 5.6% - 14.1%
- oxycodone: 23% - 24%
- oxymorphone: 1.9% - 19.1%
- paclitaxel
- paliperidone: common, 6% - 26%
- palonosetron
- pamidronate: common, 0% - 6%
- pantoprazole: postmarketing
- paricalcitol
- paroxetine: postmarketing, common, 1.4% - 22%
- pazopanib
- penciclovir: postmarketing
- penicillin
- pentazocine
- pentobarbital
- pentostatin
- perampanel: 9% - 18%
- pergolide: frequent, 10.1%
- perindopril
- perindopril erbumine
- phenobarbital
- phenylbutyric acid
- phenytoin: 6.7% - 27.3%
- pilocarpine
- pimozide: postmarketing, 25% - 27.8%
- pirfenidone
- piroxicam
- pixantrone
- posaconazole
- pramipexole: postmarketing, common, very common, 6% - 36%
- praziquantel: postmarketing
- pregabalin: 2% - 35.7%
- progesterone: postmarketing
- promethazine
- propafenone: 0.794% - 2.94%
- propofol
- propoxyphene
- propoxyphene napsylate
- propranolol: 0.9% - 5%
- prostacyclin
- pyridoxine
- quetiapine: 2.63% - 57%
- quinapril
- quinaprilat
- rabeprazole
- raltegravir
- ramelteon: 0.8% - 5%
- ramipril: 1.7%
- ramiprilat
- ranitidine
- ranolazine
- rapamycin
- rasagiline: 4% - 6%
- reboxetine: 3.67%
- regadenoson: uncommon
- remifentanil: 0% - 2.44%
- retigabine: 3% - 27%
- retinoic acid
- ribavirin: common
- rifapentine
- rilpivirine
- riluzole: 0.8% - 4.1%
- rimantadine
- risperidone: 0% - 67%
- ritonavir: 0% - 2.6%
- rivastigmine: uncommon, common, 1% - 6%
- rizatriptan: 4% - 8%
- rofecoxib
- ropinirole: 1.3% - 40%
- ropivacaine: 0.6% - 1.3%
- rotigotine: postmarketing, 8% - 32%
- rufinamide: 11% - 17%
- salbutamol: 0% - 2%
- salmon calcitonin acetate
- saquinavir: postmarketing, uncommon
- scopolamine
- secobarbital
- sertraline: very common, 1% - 15%
- sevoflurane
- sibutramine
- sildenafil: postmarketing, uncommon
- sitagliptin: postmarketing
- sitaxsentan
- sodium acetate
- sodium ferric gluconate
- solifenacin: postmarketing
- sparfloxacin: 1.5%
- stavudine
- sufentanil
- sulindac
- suvorexant: 7%
- tacrolimus
- tadalafil
- tamsulosin: 2.5% - 4.27%
- tapentadol: 12% - 15%
- technetium-99m
- telavancin: uncommon
- telithromycin
- telmisartan: rare, uncommon, 0.4%
- temozolomide: common, 1% - 9.49%
- temsirolimus
- tenofovir disoproxil fumarate
- terazosin: 0.6% - 5.4%
- terbutaline: 5.5%
- tetrabenazine: 31%
- thalidomide: 11.4% - 37.5%
- thiotepa
- tiagabine: 1% - 21%
- tigecycline
- timolol: postmarketing
- tipranavir: uncommon
- tizanidine: postmarketing, 3% - 92%
- tolcapone: 18%
- tolterodine: 3%
- topiramate: postmarketing, rare, 0% - 30.1%
- tramadol: 4.34% - 30.2%
- tramazoline
- trandolapril
- trazodone: 3.96% - 46%
- triazolam
- tropisetron
- trospium chloride: postmarketing
- trovafloxacin
- v 1784: postmarketing
- valdecoxib
- valganciclovir
- valproate: 1% - 31%
- valsartan
- vardenafil
- varenicline: frequent, 2% - 3%
- venlafaxine: postmarketing, 2% - 26.1%
- verapamil: postmarketing
- vernakalant
- vigabatrin: very common, 6% - 26%
- vilazodone: 3%
- voriconazole: rare
- zalcitabine
- zaleplon: 5% - 6%
- ziconotide: 10% - 17%
- zidovudine: postmarketing, rare, 8%
- zidovudine/lamivudine
- zileuton
- ziprasidone: 4.7% - 31%
- zoledronic acid: uncommon
- zolmitriptan: 1% - 8%
- zolpidem: postmarketing, common, 1% - 15%
- zonisamide: 17%
- zopiclone: 8% - 10%
- zuclopenthixol
|
Drugs with this indication
|
